{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:21:27Z","timestamp":1791901287913,"version":"4.3.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05907-z","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:07:17Z","timestamp":1751404037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 MPro protein - an in silico and cell-based approach"],"prefix":"10.1038","volume":"15","author":[{"given":"Khushboo","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Patten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dimet-Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley J.","family":"Watowich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Leverett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"5907_CR1","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1038\/s41586-020-2202-3","volume":"580","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. Author correction: A new coronavirus associated with human respiratory disease in China. Nature 580, E7 (2020).","journal-title":"Nature"},{"key":"5907_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"AE Gorbalenya","year":"2020","unstructured":"Gorbalenya, A. E. et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it SARS-COV-2. Nat. Microbiol. 5, 536\u2013544 (2020).","journal-title":"Nat. Microbiol."},{"key":"5907_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/20477724.2021.1890887","volume":"115","author":"LE Galan","year":"2021","unstructured":"Galan, L. E. et al. Phase 2 randomized study on chloroquine, hydroxychloroquine or Ivermectin in hospitalized patients with severe manifestations of SARS-COV-2 infection. Pathog Glob Health. 115, 235\u2013242 (2021).","journal-title":"Pathog Glob Health"},{"key":"5907_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s12879-021-06348-5","volume":"21","author":"J Vallejos","year":"2021","unstructured":"Vallejos, J. et al. Ivermectin to prevent hospitalizations in patients with covid-19 (IVERCOR-covid19) a randomized, double-blind, placebo-controlled trial. BMC Infect. Dis. 21, 635 (2021).","journal-title":"BMC Infect. Dis."},{"key":"5907_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40011-011-0016-7","volume":"82","author":"BN Dhawan","year":"2012","unstructured":"Dhawan, B. N. Anti-viral activity of Indian plants. Proc. Natl. Acad. Sci. India Sect. B Biol. Sci. 82, 209\u2013224 (2012).","journal-title":"Proc. Natl. Acad. Sci. India Sect. B Biol. Sci."},{"key":"5907_CR6","first-page":"pp14","volume":"9","author":"HCC M","year":"2014","unstructured":"M., H. C. C. et al. Phytochemical, antioxidant and microbial inhibitory effects of spondias mombin leaf and stem bark extracts. IOSR J. Pharm. Biol. Sci. 9, pp14\u201317 (2014).","journal-title":"IOSR J. Pharm. Biol. Sci."},{"key":"5907_CR7","doi-asserted-by":"publisher","first-page":"153361","DOI":"10.1016\/j.phymed.2020.153361","volume":"85","author":"K Khanna","year":"2021","unstructured":"Khanna, K. et al. Herbal Immune-boosters: substantial warriors of pandemiccovid-19 battle. Phytomedicine 85, 153361 (2021).","journal-title":"Phytomedicine"},{"key":"5907_CR8","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1016\/j.joim.2020.02.004","volume":"18","author":"C Ling","year":"2020","unstructured":"Ling, C. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-COV-2). J. Integr. Med. 18, 8788 (2020).","journal-title":"J. Integr. Med."},{"key":"5907_CR9","doi-asserted-by":"publisher","first-page":"589044","DOI":"10.3389\/fphar.2020.589044","volume":"11","author":"J Remali","year":"2021","unstructured":"Remali, J. & Aizat, W. M. A review on plant bioactive compounds and their modes of action against coronavirus infection. Front. Pharmacol. 11, 589044 (2021).","journal-title":"Front. Pharmacol."},{"key":"5907_CR10","doi-asserted-by":"crossref","unstructured":"Fei, J. et al. Contribution of traditional Chinese medicine combined with conventional Western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta\u2010analysis. Phytother. Res. 35, 5992\u20136009 (2021).","DOI":"10.1002\/ptr.7209"},{"key":"5907_CR11","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1021\/acs.jmedchem.7b01120","volume":"61","author":"AD Lawson","year":"2017","unstructured":"Lawson, A. D., MacCoss, M. & Heer, J. P. Importance of rigidity in designing small molecule drugs to tackle protein\u2013protein interactions (ppis) through stabilization of desired conformers. J. Med. Chem. 61, 4283\u20134289 (2017).","journal-title":"J. Med. Chem."},{"key":"5907_CR12","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1039\/c3np70052f","volume":"30","author":"CJ Henrich","year":"2013","unstructured":"Henrich, C. J. & Beutler, J. A. Matching the power of high throughput screening to the chemical diversity of natural products. Nat. Prod. Rep. 30, 1284 (2013).","journal-title":"Nat. Prod. Rep."},{"key":"5907_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3389\/fgene.2019.00368","volume":"10","author":"JD Romano","year":"2019","unstructured":"Romano, J. D. & Tatonetti, N. P. Informatics and computational methods in natural product drug discovery: A review and perspectives. Front. Genet. 10, 368 (2019).","journal-title":"Front. Genet."},{"key":"5907_CR14","first-page":"D1118","volume":"CMAUP","author":"X Zeng","year":"2018","unstructured":"Zeng, X. et al. A database of collective molecular activities of useful plants. Nucleic Acids Res. CMAUP, 47, D1118\u2013D1127 (2018).","journal-title":"Nucleic Acids Res."},{"key":"5907_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable Bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"5907_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265\u2013269 (2020).","journal-title":"Nature"},{"key":"5907_CR17","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1093\/emboj\/cdf327","volume":"21","author":"K Anand","year":"2002","unstructured":"Anand, K. et al. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra \u03b1-helical domain. EMBO J. 21, 3213\u20133224 (2002).","journal-title":"EMBO J."},{"key":"5907_CR18","doi-asserted-by":"crossref","unstructured":"Yang, H. et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. 100, 13190\u201313195 (2003).","DOI":"10.1073\/pnas.1835675100"},{"key":"5907_CR19","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1128\/JVI.02114-07","volume":"82","author":"X Xue","year":"2008","unstructured":"Xue, X. et al. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. J. Virol. 82, 2515\u20132527 (2008).","journal-title":"J. Virol."},{"key":"5907_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s13238-013-2841-3","volume":"4","author":"Z Ren","year":"2013","unstructured":"Ren, Z. et al. The newly emerged SARS-like coronavirus HCoV-EMC also has an achilles\u2019 heel: current effective inhibitor targeting a 3\u00a0C-like protease. Protein Cell. 4, 248\u2013250 (2013).","journal-title":"Protein Cell."},{"key":"5907_CR21","doi-asserted-by":"publisher","first-page":"22677","DOI":"10.1038\/srep22677","volume":"6","author":"F Wang","year":"2016","unstructured":"Wang, F. et al. Structure of main protease from human coronavirus NL63: insights for wide spectrum anti-coronavirus drug design. Sci. Rep. 6, 22677 (2016).","journal-title":"Sci. Rep."},{"key":"5907_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin, Z. et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289\u2013293 (2020).","journal-title":"Nature"},{"key":"5907_CR23","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1038\/s41467-020-16954-7","volume":"11","author":"DW Kneller","year":"2020","unstructured":"Kneller, D. W., Kovalevsky, A. & Coates, L. Structural plasticity of the SARS-COV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography. Nat. Commun. 11, 3202 (2020).","journal-title":"Nat. Commun."},{"key":"5907_CR24","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.3390\/ijms21093099","volume":"21","author":"M Bz\u00f3wka","year":"2020","unstructured":"Bz\u00f3wka, M. et al. Structural and evolutionary analysis indicate that the SARS-CoV-2 Mpro is a challenging target for Small-Molecule inhibitor design. Int. J. Mol. Sci. 21, 3099 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"5907_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1021\/acsptsci.0c00215","volume":"4","author":"J Gossen","year":"2021","unstructured":"Gossen, J. et al. A blueprint for high affinity SARS-CoV-2 Mpro inhibitors from Activity-Based compound library screening guided by analysis of protein dynamics. ACS Pharmacol. Transl Sci. 4, 1079\u20131095 (2021).","journal-title":"ACS Pharmacol. Transl Sci."},{"key":"5907_CR26","doi-asserted-by":"publisher","first-page":"e77433","DOI":"10.7554\/eLife.77433","volume":"11","author":"JM Flynn","year":"2022","unstructured":"Flynn, J. M. et al. Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms. Elife 11, e77433 (2022).","journal-title":"Elife"},{"key":"5907_CR27","doi-asserted-by":"publisher","first-page":"061102","DOI":"10.1063\/5.0013029","volume":"30","author":"E Estrada","year":"2020","unstructured":"Estrada, E. Topological analysis of SARS CoV-2 main protease. Chaos 30, 061102 (2020).","journal-title":"Chaos"},{"key":"5907_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejmech.2018.10.010","volume":"160","author":"P Abranyi-Balogh","year":"2018","unstructured":"Abranyi-Balogh, P. et al. A road map for prioritizing warheads for cysteine targeting covalent inhibitors. Eur. J. Med. 160, 94\u2013107 (2018).","journal-title":"Eur. J. Med."},{"key":"5907_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd3410","volume":"4","author":"J Singh","year":"2011","unstructured":"Singh, J., Peter, R. C., Baillie, T. A. & Whitty, A. The. Resurgence of covalent drugs. Nat. Rev. Drug Discov. 4, 307\u2013317 (2011).","journal-title":"Nat. Rev. Drug Discov"},{"key":"5907_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.drudis.2015.05.005","volume":"20","author":"RA Bauer","year":"2015","unstructured":"Bauer, R. A. Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies. Drug Discovery Today. 20, 1061\u20131073 (2015).","journal-title":"Drug Discovery Today"},{"key":"5907_CR31","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1021\/acs.jmedchem.1c00509","volume":"65","author":"N Kitamura","year":"2022","unstructured":"Kitamura, N. Expedited approach toward the rational design of noncovalent SARS-CoV-2 main protease inhibitors. J. Med. Chem. 65, 2848\u20132865 (2022).","journal-title":"J. Med. Chem."},{"key":"5907_CR32","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1007\/s12010-021-03608-7","volume":"193","author":"KK Bharadwaj","year":"2021","unstructured":"Bharadwaj, K. K. et al. Macrolactin A as a novel inhibitory agent for SARS-CoV-2 Mpro: bioinformatics approach. Appl. Biochem. Biotechnol. 193, 3371\u20133394 (2021).","journal-title":"Appl. Biochem. Biotechnol."},{"key":"5907_CR33","doi-asserted-by":"publisher","first-page":"603037","DOI":"10.3389\/fmolb.2020.603037","volume":"7","author":"AAA Abdusalam","year":"2020","unstructured":"Abdusalam, A. A. A. & Murugaiyah, V. Identification of potential inhibitors of 3CL protease of SARS-CoV-2 from ZINC database by molecular Docking-Based virtual screening. Front. Mol. Biosci. 7, 603037 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"5907_CR34","doi-asserted-by":"publisher","first-page":"33151","DOI":"10.1021\/acsomega.0c04808","volume":"5","author":"A Gupta","year":"2020","unstructured":"Gupta, A. et al. Structure-Based virtual screening and biochemical validation to discover a potential inhibitor of the SARS-CoV-2 main protease. ACS Omega. 5, 33151\u201333161 (2020).","journal-title":"ACS Omega"},{"key":"5907_CR35","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.1038\/s41598-021-86471-0","volume":"11","author":"YL Weng","year":"2021","unstructured":"Weng, Y. L. et al. Molecular dynamics and in Silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity. Sci. Rep. 11, 7429 (2021).","journal-title":"Sci. Rep."},{"key":"5907_CR36","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1021\/ct500381c","volume":"10","author":"JD Durrant","year":"2014","unstructured":"Durrant, J. D. et al. POVME 2.0: an enhanced tool for determining pocket shape and volume characteristics. J. Chem. Theory Comput. 10, 5047\u20135056 (2014).","journal-title":"J. Chem. Theory Comput."},{"key":"5907_CR37","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1021\/acs.jctc.7b00500","volume":"13","author":"JR Wagner","year":"2017","unstructured":"Wagner, J. R. et al. POVME 3.0: software for mapping binding pocket flexibility. J. Chem. Theory Comput. 13, 4584\u20134592 (2017).","journal-title":"J. Chem. Theory Comput."},{"key":"5907_CR38","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.str.2021.07.007","volume":"29","author":"S Durdagi","year":"2021","unstructured":"Durdagi, S. et al. Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing. Structure 29, 1382\u20131396 (2021).","journal-title":"Structure"},{"key":"5907_CR39","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1021\/acs.jcim.1c00140","volume":"61","author":"T Sztain","year":"2021","unstructured":"Sztain, T., Amaro, R. & McCammon, J. A. Elucidation of cryptic and allosteric pockets within the SARS-CoV-2 protease. J. Chem. Inf. Model. 61, 3495\u20133501 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"5907_CR40","doi-asserted-by":"publisher","first-page":"962863","DOI":"10.3389\/fphar.2022.962863","volume":"13","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular Docking. Front. Pharmacol. 13, 962863 (2022).","journal-title":"Front. Pharmacol."},{"key":"5907_CR41","doi-asserted-by":"publisher","unstructured":"da Fonseca, A. M. et al. Screening of Potential Inhibitors Targeting the Main Protease Structure of SARS-CoV-2 via Molecular Docking, and Approach with Molecular Dynamics, RMSD, RMSF, H-Bond, SASA and MMGBSA. Mol. Biotechnol. Preprint at (2023). https:\/\/doi.org\/10.1007\/s12033-023-00831-x","DOI":"10.1007\/s12033-023-00831-x"},{"key":"5907_CR42","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s11224-022-02031-w","volume":"33","author":"DM Teli","year":"2022","unstructured":"Teli, D. M. et al. Fragment-based design of SARS-CoV-2 Mpro inhibitors. Struct. Chem. 33, 2155\u20132168 (2022).","journal-title":"Struct. Chem."},{"key":"5907_CR43","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1134\/S0036024422070251","volume":"96","author":"RMAQ Jamhour","year":"2022","unstructured":"Jamhour, R. M. A. Q. et al. Phytochemicals as a potential inhibitor of COVID-19: an In-Silico perspective. Russ J. Phys. Chem. 96, 1589\u20131597 (2022).","journal-title":"Russ J. Phys. Chem."},{"key":"5907_CR44","doi-asserted-by":"crossref","unstructured":"Agrawal, P. K. & Blunden, G. Phytochemicals against SARS-COV-2 infection. Nat. Prod. Commun. 18 (2023).","DOI":"10.1177\/1934578X231152168"},{"key":"5907_CR45","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3389\/fimmu.2020.01451","volume":"11","author":"RMLC Biancatelli","year":"2020","unstructured":"Biancatelli, R. M. L. C., Berrill, M., Catravas, J. & Marik, P. E. Quercetin and vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19). Front. Immunol. 11, 1451 (2020).","journal-title":"Front. Immunol."},{"key":"5907_CR46","doi-asserted-by":"publisher","first-page":"197989","DOI":"10.1016\/j.virusres.2020.197989","volume":"284","author":"JS Mani","year":"2020","unstructured":"Mani, J. S. et al. Natural product-derived phytochemicals as potential agents against coronaviruses: a review. Virus Res. 284, 197989 (2020).","journal-title":"Virus Res."},{"key":"5907_CR47","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.3390\/plants11141862","volume":"11","author":"SS Issa","year":"2022","unstructured":"Issa, S. S. et al. The main protease of SARS-CoV-2 as a target for phytochemicals against coronavirus. Plants 11, 1862 (2022).","journal-title":"Plants"},{"key":"5907_CR48","unstructured":"AP11.0. SimulationsPlus LLC, Lancaster, CA."},{"key":"5907_CR49","unstructured":"Cayman Chemical Company. Demethoxycurcumin. Item Number 10961. (2024).  https:\/\/www.caymanchem.com\/product\/10961\/demethoxycurcumin"},{"key":"5907_CR50","unstructured":"Cayman Chemical Company. Shikonin. Item Number 14751. (2024). https:\/\/www.caymanchem.com\/product\/14751\/shikonin"},{"key":"5907_CR51","unstructured":"Cayman Chemical Company. Withaferin A. Item Number 11352. (2024).  https:\/\/www.caymanchem.com\/product\/11352\/withaferin-a"},{"key":"5907_CR52","doi-asserted-by":"crossref","unstructured":"Alici, H., Tahtaci, H. & Demir, K. Design and various in Silico studies of the novel Curcumin derivatives as potential candidates against COVID-19 -associated main enzymes. Comput Biol. Chem (2022).","DOI":"10.1016\/j.compbiolchem.2022.107657"},{"key":"5907_CR53","doi-asserted-by":"publisher","first-page":"e11590","DOI":"10.7717\/peerj.11590","volume":"9","author":"A Mulu","year":"2021","unstructured":"Mulu, A. et al. The impact of curcumin-derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study. PeerJ 9, e11590 (2021).","journal-title":"PeerJ"},{"key":"5907_CR54","doi-asserted-by":"publisher","unstructured":"Khaerunnisa, S., Kurniawan, H., Awaluddin, R., Suhartati, S. & Soetjipto, S. Potential Inhibitor of COVID-19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study. Preprint at (2020). https:\/\/doi.org\/10.20944\/preprints202003.0226.v1","DOI":"10.20944\/preprints202003.0226.v1"},{"key":"5907_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00894-021-04703-6","volume":"27","author":"A Ghosh","year":"2021","unstructured":"Ghosh, A. et al. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as a potential therapeutic lead against the main protease (Mpro) of SARS-CoV-2. J. Mol. Model. 27, 97 (2021).","journal-title":"J. Mol. Model."},{"key":"5907_CR56","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1021\/acs.jnatprod.2c00521","volume":"85","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty, S. et al. The natural products Withaferin A and withanone from the medicinal herb Withania somnifera are covalent inhibitors of the SARS-CoV-2 main protease. J. Nat. Prod. 85, 2340\u20132350 (2022).","journal-title":"J. Nat. Prod."},{"key":"5907_CR57","doi-asserted-by":"publisher","first-page":"e0125321","DOI":"10.1128\/JVI.01253-21","volume":"96","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Structure-Based discovery and structural basis of a novel Broad-Spectrum natural product against the main protease of coronavirus. J. Virol. 96, e0125321 (2022).","journal-title":"J. Virol."},{"key":"5907_CR58","doi-asserted-by":"crossref","unstructured":"Ma, C. et al. Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin are nonspecific promiscuous SARS-CoV-2 main protease inhibitors. ACS Pharmacol. Transl Sci. 3, 1265\u20131277 (2020).","DOI":"10.1021\/acsptsci.0c00130"},{"key":"5907_CR59","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1080\/07391102.2020.1776157","volume":"39","author":"S Gupta","year":"2021","unstructured":"Gupta, S. et al. Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular Docking and simulation studies. J. Biomol. Struct. Dyn. 39, 4334\u20134345 (2021).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"5907_CR60","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1021\/jm300288g","volume":"55","author":"H Lachance","year":"2012","unstructured":"Lachance, H. et al. Charting, navigating, and populating natural product chemical space for drug discovery. J. Med. Chem. 55, 5989\u20136001 (2012).","journal-title":"J. Med. Chem."},{"key":"5907_CR61","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12298-022-01146-y","volume":"28","author":"S Kaur","year":"2022","unstructured":"Kaur, S. et al. How do plants defend themselves against pathogens-Biochemical mechanisms and genetic interventions. Physiol. Mol. Biol. Plants. 28, 485\u2013504 (2022).","journal-title":"Physiol. Mol. Biol. Plants"},{"key":"5907_CR62","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1080\/07391102.2020.1842806","volume":"6","author":"PJ Sharma","year":"2022","unstructured":"Sharma, P. J. Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM\/PBSA methods. J. Biomol. Struc T Dyn. 6, 2757\u20132768 (2022).","journal-title":"J. Biomol. Struc T Dyn."},{"key":"5907_CR63","doi-asserted-by":"publisher","first-page":"106785","DOI":"10.1016\/j.compbiomed.2023.106785","volume":"157","author":"A Hossain","year":"2023","unstructured":"Hossain, A. Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (Mpro) using molecular Docking and deep learning methods. Comput. Biol. Med. 157, 106785 (2023).","journal-title":"Comput. Biol. Med."},{"key":"5907_CR64","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s11030-021-10211-9","volume":"3","author":"B Gogoi","year":"2021","unstructured":"Gogoi, B. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Mol. Divers. 3, 1963\u20131977 (2021).","journal-title":"Mol. Divers."},{"key":"5907_CR65","doi-asserted-by":"publisher","first-page":"e202200655","DOI":"10.1002\/cbdv.202200655","volume":"11","author":"J Choe","year":"2022","unstructured":"Choe, J., Yong, H. P. & Xiang, N. Z. The efficacy of traditional medicinal plants in modulating the main protease of SARS-CoV-2 and cytokine storm. Chem. Biodivers. 11, e202200655 (2022).","journal-title":"Chem. Biodivers."},{"key":"5907_CR66","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1080\/07391102.2022.2062787","volume":"9","author":"P Choudhary","year":"2023","unstructured":"Choudhary, P., Singh, T., Amod, A. & Singh, S. Evaluation of phytoconstituents of Tinospora cordifolia against K417N and N501Y mutant Spike glycoprotein and main protease of SARS-CoV-2- an in Silico study. J. Biomol. Struct. Dyn. 9, 4106\u20134123 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"5907_CR67","unstructured":"Protein Data Bank.  (2023). https:\/\/www.rcsb.org. Retrieved 29 Aug 2023."},{"key":"5907_CR68","doi-asserted-by":"publisher","unstructured":"Zhang, L. & Hilgenfeld, R. Crystal structure of SARS-CoV-2 Mpro in complex with the activity-based probe, biotin-PEG(4)-Abu-Tle-Leu-Gln-vinylsulfone. https:\/\/doi.org\/10.2210\/pdb6Z2E\/pdb (2020).","DOI":"10.2210\/pdb6Z2E\/pdb"},{"key":"5907_CR69","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.abb4489","volume":"368","author":"W Dai","year":"2020","unstructured":"Dai, W., Zhang, B., Jiang, X. M., Su, H. & Li, J. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science 368, 1331\u20131335 (2020).","journal-title":"Science"},{"key":"5907_CR70","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1126\/science.1085658","volume":"300","author":"K Anand","year":"2020","unstructured":"Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R. & Hilgenfeld, R. Coronavirus main proteinase (3CLpro) structure: basis for the design of anti-SARS drugs. Science 300, 1763\u20131767 (2020).","journal-title":"Science"},{"key":"5907_CR71","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.4155\/fmc-2020-0165","volume":"12","author":"WR Ferraz","year":"2020","unstructured":"Ferraz, W. R., Gomes, R. A., Al, S. N. & Trossini, G. Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in Silico repurposing study. Future Med. Chem. 12, 1815\u20131828 (2020).","journal-title":"Future Med. Chem."},{"key":"5907_CR72","doi-asserted-by":"publisher","first-page":"17365","DOI":"10.1074\/jbc.AC120.016154","volume":"50","author":"DW Kneller","year":"2020","unstructured":"Kneller, D. W. Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography. J. Biol. Chem. 50, 17365\u201317373 (2020).","journal-title":"J. Biol. Chem."},{"key":"5907_CR73","doi-asserted-by":"publisher","first-page":"e0240653","DOI":"10.1371\/journal.pone.0240653","volume":"15","author":"SA Cherrak","year":"2020","unstructured":"Cherrak, S. A., Merzouk, H. & Mokhtari-Soulimane, N. Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular Docking and simulation studies. PLoS One. 15, e0240653 (2020).","journal-title":"PLoS One"},{"key":"5907_CR74","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/1389201022666210322124348","volume":"2","author":"RK Harwansh","year":"2022","unstructured":"Harwansh, R. K. & Bahadur, S. Herbal medicines to fight against COVID-19: new battle with an old weapon. Curr. Pharm. Biotechnol. 2, 235\u2013260 (2022).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"5907_CR75","doi-asserted-by":"crossref","unstructured":"Xu, H., Li, S. & Liu, J. Bioactive compounds from Haushi Baidu decoction possess both anti-viral and anti-inflammataory effects against COVID-19. Proc. Natl. Acad. Sci. USA  18, e2301775120 (2023).","DOI":"10.1073\/pnas.2301775120"},{"key":"5907_CR76","first-page":"22398","volume":"11","author":"AE Allam","year":"2021","unstructured":"Allam, A. E. .al.In silico study of natural compounds from sesame against COVID-19 by targeting Mpro, PLpro and RdRp. R Soc. Chem. 11, 22398 (2021).","journal-title":"R Soc. Chem."},{"key":"5907_CR77","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.csbj.2022.03.009","volume":"20","author":"I Antonopoulou","year":"2020","unstructured":"Antonopoulou, I., Sapountzaki, E., Rova, U. & Christakopoulos, P. Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing\/designing drug-like substances and utilizing nature\u2019s toolbox of bioactive compounds. Comput. Struct. Biotechnol. J. 20, 1306\u20131344 (2020).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"5907_CR78","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","volume":"10","author":"MT Ul Qamar","year":"2020","unstructured":"Ul Qamar, M. T., Alqahtani, S. M., Alamri, M. A. & Chen, L. L. Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal. 10, 313\u2013319 (2020).","journal-title":"J. Pharm. Anal."},{"key":"5907_CR79","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00705-022-05483-x","volume":"167","author":"TMM Ngwe","year":"2022","unstructured":"Ngwe, T. M. M. Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro. Arch. Virol. 167, 1547\u20131557 (2022).","journal-title":"Arch. Virol."},{"key":"5907_CR80","doi-asserted-by":"publisher","first-page":"46400","DOI":"10.1016\/j.scitotenv.2021.146400","volume":"781","author":"MA Z\u00edgolo","year":"2021","unstructured":"Z\u00edgolo, M. A., Goytia, M. R., Poma, H. R., Rajal, V. B. & Irazusta, V. P. Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools. Sci. Total Environ. 781, 46400 (2021).","journal-title":"Sci. Total Environ."},{"key":"5907_CR81","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","volume":"41","author":"HX Su","year":"2020","unstructured":"Su, H. X. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol. Sin. 41, 1167\u20131177 (2020).","journal-title":"Acta Pharmacol. Sin"},{"key":"5907_CR82","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/molecules26071924","volume":"26","author":"TTH Nguyen","year":"2021","unstructured":"Nguyen, T. T. H. The inhibitory effects of plant derivate polyphenols on the main protease of SARS coronavirus 2 and their Structure-Activity relationship. Molecules 26, 1924 (2021).","journal-title":"Molecules"},{"key":"5907_CR83","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.virol.2022.03.003","volume":"570","author":"MK El-Ashrey","year":"2022","unstructured":"El-Ashrey, M. K., Bakr, R. O., Fayed, M. A. A., Refaey, R. H. & Nissan, Y. M. Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease. Virology 570, 18\u201328 (2022).","journal-title":"Virology"},{"key":"5907_CR84","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1038\/s41467-020-18709-w","volume":"11","author":"A Douangamath","year":"2020","unstructured":"Douangamath, A., Fearon, D., Gehrtz, P., Krojer, T. & Lukacik, P. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nat. Commun. 11, 5047 (2020).","journal-title":"Nat. Commun."},{"key":"5907_CR85","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"GROMACS","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX GROMACS, 1, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"5907_CR86","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jcc.23354","volume":"34","author":"J Huang","year":"2013","unstructured":"Huang, J. & MacKerell, A. D. Jr. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J. Comput. Chem. 34, 2135\u20132145 (2013).","journal-title":"J. Comput. Chem."},{"key":"5907_CR87","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926 (1983).","journal-title":"J. Chem. Phys."},{"key":"5907_CR88","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh ewald: an N\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092 (1993).","journal-title":"J. Chem. Phys."},{"key":"5907_CR89","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/cbdd.13653","volume":"95","author":"K Singh","year":"2020","unstructured":"Singh, K. & Briggs, J. M. Impact of lymphoma-linked Asn11Tyr point mutation on the interaction between Bcl-2 and a BH3 mimetic: insights from molecular dynamics simulation. Chem. Biol. Drug Des. 95, 435\u2013450 (2020).","journal-title":"Chem. Biol. Drug Des."},{"key":"5907_CR90","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"H Berendsen","year":"1984","unstructured":"Berendsen, H., Postma, J., van Gunsteren, W., DiNola, A. & Haak, J. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684\u20133690 (1984).","journal-title":"J. Chem. Phys."},{"key":"5907_CR91","doi-asserted-by":"crossref","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: A linear constraint solver for molecular simulations. J Comp. Chem 18  (1997).","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L"},{"key":"5907_CR92","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD - Visual molecular dynamics. J. Mol. Graphics. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graphics"},{"key":"5907_CR93","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"E Pettersen","year":"2004","unstructured":"Pettersen, E. et al. UCSF Chimera - A visualization system for exploratory research and analysis. J. Comp. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comp. Chem."},{"key":"5907_CR94","unstructured":"Schr\u00f6dinger Release 2022-4. Protein Preparation Wizard; Epik, Schr\u00f6dinger (LLC, 2022)."},{"key":"5907_CR95","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/jcc.20292","volume":"26","author":"JL Banks","year":"2005","unstructured":"Banks, J. L. et al. Integrated modeling program applied chemical theory (IMPACT). J. Comp. Chem. 26, 1752\u20131780 (2005).","journal-title":"J. Comp. Chem."},{"key":"5907_CR96","unstructured":"Schr\u00f6dinger Release 2022-4. Glide (Schr\u00f6dinger, LLC, 2022)."},{"key":"5907_CR97","unstructured":"Schr\u00f6dinger Release 2022-4: LigPrep.  (Schr\u00f6dinger, LLC,  2022)."},{"key":"5907_CR98","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/prot.23106","volume":"79","author":"J Li","year":"2011","unstructured":"Li, J. et al. The VSGB 2.0 model: a next-generation energy model for high-resolution protein structure modeling. Proteins 79, 2794\u20132812 (2011).","journal-title":"Proteins"},{"key":"5907_CR99","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.scitotenv.2013.06.081","volume":"463\u2013464","author":"CI Cappelli","year":"2013","unstructured":"Cappelli, C. I., Manganelli, S., Lombardo, A., Gissi, A. & Benfenati, E. Validation of quantitative structure-activity relationship models to predict water-solubility of organic compounds. Sci. Total Environ. 463\u2013464, 781\u2013789 (2013).","journal-title":"Sci. Total Environ."},{"key":"5907_CR100","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1517\/17460441.1.1.31","volume":"1","author":"JC Dearden","year":"2006","unstructured":"Dearden, J. C. In Silico prediction of aqueous solubility. Expet Opin. Drug Discov. 1, 31\u201352 (2006).","journal-title":"Expet Opin. Drug Discov"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05907-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05907-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05907-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T22:03:47Z","timestamp":1751407427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05907-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5907"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05907-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3888947\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"22 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22840"}}